Vanguard Portfolio Management LLC has filed a Schedule 13G/A with the SEC, revealing its significant ownership stake in National Vision Holdings, Inc. The filing, dated October 30, 2026, shows that Vanguard now holds 4,809,407 shares of National Vision, representing 6.08% of the company. This substantial investment highlights Vanguard's ongoing strategy to enhance its portfolio within the ophthalmic goods industry.

National Vision Holdings, Inc. is a key player in the ophthalmic goods sector, which includes companies involved in the manufacturing and retailing of eyewear and related products. The company is headquartered in Duluth, Georgia, and operates under the Central Index Key (CIK) number 0001710155. This filing is part of a series of recent disclosures from Vanguard, indicating a proactive approach to managing its investments.

The Schedule 13G/A filing indicates that Vanguard has sole voting power over 56,145 shares and sole dispositive power over the entire 4.8 million shares reported. This level of ownership allows Vanguard to influence decisions at National Vision, particularly as the company continues to navigate a competitive market landscape.

This update may affect various stakeholders, including investors and competitors in the ophthalmic goods industry. Vanguard's increased stake could signal confidence in National Vision's growth prospects, potentially impacting how other companies in the sector strategize moving forward.

Details were not available in the SEC filing regarding future actions or plans related to this investment. Vanguard's filing does not specify any immediate changes or votes that may arise from this ownership stake.